Costs of illness due to Bordetella pertussis in families

Archives of Family Medicine

Volumn 9, Issue 10, 2000, Pages 989-996

  Lee, L H ^a   Pichichero, M E ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CONVALESCENCE; HEALTH CARE COST; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MORBIDITY; PERTUSSIS; PRODUCTIVITY; PROSPECTIVE STUDY;

EID: 0034545438     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.9.10.989     Document Type: Article

References (34)

1. Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination
2. Resurgence of pertussis: United States, 1993
3. Summary of notifiable diseases: United States, 1996
4. Quarterly immunization table
5. Prevalence and incidence of adult pertussis in an urban population
6. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan
7. Economic impact of pertussis
8. Serological response to Bordetella pertussis
9. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines
10. Widespread silent transmission of pertussis in families: Antibody correlates of infection and symptomatology
11. Intrafamilial spread of pertussis
12. The changing epidemiology of pertussis in young infants: The role of adults as reservoirs of infection
13. Unrecognized pertussis infection in adolescents
14. Adult immunization with acellular pertussis vaccine
15. Pertussis in Massachusetts, 1981-1991: Incidence, serologic diagnosis, and vaccine effectiveness
16. A search for Bordetella pertussis infection in university students
17. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
18. Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis
19. Pertussis in Missouri: Evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis
20. Bordetella pertussis isolation in general practice: 1977-79 Whooping cough epidemic in West Glamorgan
21. A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled
22. Sensitivity and specificity of clinical case definitions for pertussis
23. Pertussis infection in adults with persistent cough
24. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis
25. The hidden payroll: Employee benefits and the structure of workplace inequality
26. Parental benefit policies and the gendered division of labor
27. Working parents: What factors are involved in their ability to take time off from work when their children are sick?
28. The relationship between work/family benefits and earnings: A test of competing predictions
29. Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997
30. Outcomes of Bordetella pertussis infection in different age groups of an immunized population
31. Duration of effectiveness of pertussis vaccine: Evidence from a 10-year community study
32. The recurrence of whooping cough: Possible implications for assessment of vaccine efficacy
33. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection